Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures

Bassil Dekky; Michael Ruff; Dominique Bonnier; Vincent Legagneux; Nathalie Théret

doi:10.18632/oncotarget.26339

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures

PDF | How to cite

Oncotarget. 2018; 9:35795-35795. https://doi.org/10.18632/oncotarget.26339

Metrics: PDF 1152 views | ?

Bassil Dekky¹, Michael Ruff^1,2,*, Dominique Bonnier^1,*, Vincent Legagneux¹ and Nathalie Théret¹

¹ Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S1085, Rennes, France
² Present address: Institute of Biology Valrose (iBV) CNRS UMR7277 - INSERM U1091 – UNS University Nice Sophia Antipolis, Nice, France
^* These authors contributed equally to this work

Published: November 06, 2018

This article has been corrected: The following sentence has been added to the first paragraph in the Material and Methods section: ‘Protein digestion and mass spectrometry analyses were performed by the Proteomics Platform of the CHU de Québec Research Center (Quebec, Qc,Canada).’

Proteomics analyses

Immunoprecipitation of proteins associated with ADAM12L were performed using extracts from ADAM12Loverexpressing MCF10A cells and immunoprecipitation using Rabbit IgG was included as control. Proteins from immunoprecipitates were denaturated and size-separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE). After cutting gel tracks in 10 bands, in-gel digestion of proteins was performed with trypsin and resulting peptides were injected into a capillary HPLC system coupled to a mass spectrometer via a nanospray ionization source (ES MS/MS). All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 2.4.1) and X! Tandem softwares. Mascot was set up to search the TAX_HomoSapiens_9606_20141128 database. X! Tandem was set up to search a subset of the TAX_HomoSapiens_9606_20141128 database. For protein identification, Scaffold software (version 4.4.1.1, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were validated when established at a probability greater than 86,0 % to achieve an FDR less than 1,0 % using the Scaffold Local FalseDiscoveryRate (FDR) algorithm. Protein identifications were validated when established at a probability greater than 99,0 % probability to achieve an FDR less than 1,0 % and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm [69]. Protein digestion and mass spectrometry analyses were performed by the Proteomics Platform of the CHU de Québec Research Center (Quebec, Qc,Canada).

Original article: Oncotarget. 2018; 9:21366-21382. DOI: https://doi.org/10.18632/oncotarget.25106.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26339

Publication Alerts

Corrections:

Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures